VENTURE CAPITAL FOR YOUNG EUROPEAN INNOVATIVE LIFE SCIENCE COMPANIES
Vesalius Biocapital Partners manages a mid-size venture capital fund that invests in young, early- and mid-stage European life science companies creating innovative drugs, diagnostics and cutting-edge biomedical technologies. They are building a diversified portfolio of companies with a balanced risk structure and with financial attractiveness translating into above average returns on investment.
ReGenius is the first European Brownfield Investment Fund, focusing on abandoned, idle or underutilized sites where expansion or redevelopment is complicated by real or perceived environmental contamination. The focus of the ReGenius Fund is aimed at brownfields situated in Western Europe, mainly the BENELUX (Belgium, the Netherlands and Luxemburg), the North of France and the German Ruhr area.